Cambridge, United Kingdom

David James Hardick

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of David James Hardick in the Field of Medicine

Introduction

David James Hardick is a distinguished inventor based in Cambridge, GB, known for his significant contributions to the field of medical research and pharmaceutical development. With a total of four patents to his name, Hardick has focused his research on compounds that inhibit the METTL3 enzyme, thereby providing new avenues for treating various proliferative disorders, such as cancer and autoimmune diseases.

Latest Patents

Among his latest inventions, Hardick has developed innovative METTL3 inhibitory compounds. These compounds, identified by the formula (I), are designed to inhibit the activity of the METTL3 (N6-adenosine-methyltransferase 70 kDa subunit) enzyme. The details of the compounds include defined structures for X, Y, and Z. This groundbreaking research is pivotal in establishing processes for the preparation of these compounds, which are included in pharmaceutical compositions aimed at treating conditions where METTL3 activity plays a critical role.

Another notable patent by Hardick is the development of polyheterocyclic compounds functioning as METTL3 inhibitors. Similar to his previous invention, this patent entails compounds defined by the same formula (I) and seeks to expand the therapeutic options available for combating proliferative disorders, autoimmune diseases, and various other medical conditions related to METTL3.

Career Highlights

Throughout his career, David James Hardick has been affiliated with esteemed organizations, including Storm Therapeutics Limited. His work has not only advanced scientific understanding in the realm of medicinal chemistry but also contributed to the pipeline of new therapies aimed at serious health challenges.

Collaborations

Hardick has collaborated with several notable professionals during his career. Among his coworkers, Wesley Peter Blackaby and Elizabeth Jane Thomas have played significant roles in his research endeavors and have contributed to advancing the projects on which he has worked.

Conclusion

David James Hardick's innovative contributions to the field of medicinal chemistry and his patents related to METTL3 inhibitors highlight his commitment to addressing critical health issues. Through his research and collaborations, he continues to pave the way for potential breakthroughs in the treatment of challenging diseases, making him a notable figure in the realm of inventors dedicated to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…